JHS Svendgaard Grants 250,000 Stock Options Under 2025 ESOP

JHS Svendgaard Laboratories Limited ( (IN:JHS) ) has shared an announcement.

JHS Svendgaard Laboratories Limited’s Nomination and Remuneration Committee has approved the grant of 250,000 employee stock options under its 2025 Employee Stock Option Scheme, each option convertible into one equity share of face value Rs. 10 at an exercise price set at par. The options, issued via fresh allotment and compliant with SEBI’s SBEB & SE Regulations, 2021, will vest over one to five years and can be exercised within five years of vesting, aligning employee incentives with long-term shareholder value and potentially modestly diluting equity upon full exercise.

The scheme’s pricing formula links the exercise price to market levels while ensuring it does not fall below face value, with the committee empowered to allow discounts within this floor. By structuring vesting and exercise windows over multiple years and targeting eligible employees based on predefined criteria, the company aims to strengthen retention, reward performance, and reinforce management commitment as it competes in its sector and navigates broader market conditions.

More about JHS Svendgaard Laboratories Limited

JHS Svendgaard Laboratories Limited operates in the Indian consumer products and manufacturing space, focusing on oral-care and related personal care products. The company is listed on both the Bombay Stock Exchange and the National Stock Exchange under the trading symbol JHS, giving it access to public capital markets and a broad base of institutional and retail investors.

Average Trading Volume: 18,462

Technical Sentiment Signal: Sell

Current Market Cap: 951.9M INR

Learn more about JHS stock on TipRanks’ Stock Analysis page.